181 related articles for article (PubMed ID: 25156521)
1. The disulfide isomerase ERp57 is required for fibrin deposition in vivo.
Zhou J; Wu Y; Wang L; Rauova L; Hayes VM; Poncz M; Essex DW
J Thromb Haemost; 2014 Nov; 12(11):1890-7. PubMed ID: 25156521
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal CGHC motif of protein disulfide isomerase supports thrombosis.
Zhou J; Wu Y; Wang L; Rauova L; Hayes VM; Poncz M; Essex DW
J Clin Invest; 2015 Nov; 125(12):4391-406. PubMed ID: 26529254
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the αIIbβ3 integrin.
Wang L; Wu Y; Zhou J; Ahmad SS; Mutus B; Garbi N; Hämmerling G; Liu J; Essex DW
Blood; 2013 Nov; 122(22):3642-50. PubMed ID: 24030382
[TBL] [Abstract][Full Text] [Related]
4. A humanized monoclonal antibody that inhibits platelet-surface ERp72 reveals a role for ERp72 in thrombosis.
Holbrook LM; Sandhar GK; Sasikumar P; Schenk MP; Stainer AR; Sahli KA; Flora GD; Bicknell AB; Gibbins JM
J Thromb Haemost; 2018 Feb; 16(2):367-377. PubMed ID: 29052936
[TBL] [Abstract][Full Text] [Related]
5. The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function.
Holbrook LM; Sasikumar P; Stanley RG; Simmonds AD; Bicknell AB; Gibbins JM
J Thromb Haemost; 2012 Feb; 10(2):278-88. PubMed ID: 22168334
[TBL] [Abstract][Full Text] [Related]
6. The disulfide isomerase ERp57 mediates platelet aggregation, hemostasis, and thrombosis.
Wu Y; Ahmad SS; Zhou J; Wang L; Cully MP; Essex DW
Blood; 2012 Feb; 119(7):1737-46. PubMed ID: 22207737
[TBL] [Abstract][Full Text] [Related]
7. The disulfide isomerase ERp72 supports arterial thrombosis in mice.
Zhou J; Wu Y; Chen F; Wang L; Rauova L; Hayes VM; Poncz M; Li H; Liu T; Liu J; Essex DW
Blood; 2017 Aug; 130(6):817-828. PubMed ID: 28576878
[TBL] [Abstract][Full Text] [Related]
8. Defective PDI release from platelets and endothelial cells impairs thrombus formation in Hermansky-Pudlak syndrome.
Sharda A; Kim SH; Jasuja R; Gopal S; Flaumenhaft R; Furie BC; Furie B
Blood; 2015 Mar; 125(10):1633-42. PubMed ID: 25593336
[TBL] [Abstract][Full Text] [Related]
9. Formation of the clot.
Furie B; Furie BC
Thromb Res; 2012 Oct; 130 Suppl 1(Suppl 1):S44-6. PubMed ID: 23026660
[TBL] [Abstract][Full Text] [Related]
10. Platelet protein disulfide isomerase is required for thrombus formation but not for hemostasis in mice.
Kim K; Hahm E; Li J; Holbrook LM; Sasikumar P; Stanley RG; Ushio-Fukai M; Gibbins JM; Cho J
Blood; 2013 Aug; 122(6):1052-61. PubMed ID: 23788140
[TBL] [Abstract][Full Text] [Related]
11. Both platelet- and endothelial cell-derived ERp5 support thrombus formation in a laser-induced mouse model of thrombosis.
Passam FH; Lin L; Gopal S; Stopa JD; Bellido-Martin L; Huang M; Furie BC; Furie B
Blood; 2015 Apr; 125(14):2276-85. PubMed ID: 25624318
[TBL] [Abstract][Full Text] [Related]
12. Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy.
Cui G; Shan L; Guo L; Chu IK; Li G; Quan Q; Zhao Y; Chong CM; Zhang Z; Yu P; Hoi MP; Sun Y; Wang Y; Lee SM
Sci Rep; 2015 Jun; 5():10353. PubMed ID: 26037049
[TBL] [Abstract][Full Text] [Related]
13. Multiple protein disulfide isomerases support thrombosis.
Essex DW; Wu Y
Curr Opin Hematol; 2018 Sep; 25(5):395-402. PubMed ID: 29994898
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum protein 5 attenuates platelet endoplasmic reticulum stress and secretion in a mouse model.
Lay AJ; Dupuy A; Hagimola L; Tieng J; Larance M; Zhang Y; Yang J; Kong Y; Chiu J; Gray E; Qin Z; Schmidt D; Maclean J; Hofma B; Ellis M; Kalev-Zylinska M; Argon Y; Jackson SP; Hogg P; Passam FH
Blood Adv; 2023 May; 7(9):1650-1665. PubMed ID: 36508284
[TBL] [Abstract][Full Text] [Related]
15. Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo.
Jasuja R; Furie B; Furie BC
Blood; 2010 Nov; 116(22):4665-74. PubMed ID: 20668226
[TBL] [Abstract][Full Text] [Related]
16. Platelet Protein Disulfide Isomerase Promotes Glycoprotein Ibα-Mediated Platelet-Neutrophil Interactions Under Thromboinflammatory Conditions.
Li J; Kim K; Jeong SY; Chiu J; Xiong B; Petukhov PA; Dai X; Li X; Andrews RK; Du X; Hogg PJ; Cho J
Circulation; 2019 Mar; 139(10):1300-1319. PubMed ID: 30586735
[TBL] [Abstract][Full Text] [Related]
17. 12(S)-HETrE, a 12-Lipoxygenase Oxylipin of Dihomo-γ-Linolenic Acid, Inhibits Thrombosis via Gαs Signaling in Platelets.
Yeung J; Tourdot BE; Adili R; Green AR; Freedman CJ; Fernandez-Perez P; Yu J; Holman TR; Holinstat M
Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2068-77. PubMed ID: 27470510
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic implications of protein disulfide isomerase inhibition in thrombotic disease.
Flaumenhaft R; Furie B; Zwicker JI
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):16-23. PubMed ID: 25104801
[TBL] [Abstract][Full Text] [Related]
19. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice.
Cho J; Furie BC; Coughlin SR; Furie B
J Clin Invest; 2008 Mar; 118(3):1123-31. PubMed ID: 18292814
[TBL] [Abstract][Full Text] [Related]
20. Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability.
Lee RH; Kawano T; Grover SP; Bharathi V; Martinez D; Cowley DO; Mackman N; Bergmeier W; Antoniak S
J Thromb Haemost; 2022 Feb; 20(2):422-433. PubMed ID: 34689407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
